X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2255) 2255
Publication (153) 153
Book Review (26) 26
Newsletter (16) 16
Magazine Article (10) 10
Book Chapter (4) 4
Newspaper Article (3) 3
Conference Proceeding (2) 2
Dissertation (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
salmeterol xinafoate (1904) 1904
humans (1841) 1841
albuterol - analogs & derivatives (1720) 1720
male (1031) 1031
asthma - drug therapy (983) 983
female (969) 969
salmeterol (907) 907
albuterol - therapeutic use (889) 889
albuterol - administration & dosage (765) 765
administration, inhalation (756) 756
adult (718) 718
middle aged (693) 693
asthma (678) 678
bronchodilator agents - therapeutic use (670) 670
respiratory system (660) 660
fluticasone (624) 624
index medicus (571) 571
bronchodilator agents - administration & dosage (553) 553
double-blind method (523) 523
aged (486) 486
drug therapy, combination (468) 468
adrenergic beta-agonists - therapeutic use (449) 449
pulmonary disease, chronic obstructive - drug therapy (413) 413
treatment outcome (403) 403
albuterol - pharmacology (387) 387
adolescent (375) 375
pharmacology & pharmacy (373) 373
androstadienes - administration & dosage (348) 348
formoterol fumarate (325) 325
albuterol - adverse effects (317) 317
adrenergic beta-agonists - administration & dosage (310) 310
asthma - physiopathology (299) 299
androstadienes - therapeutic use (269) 269
fluticasone propionate (263) 263
child (262) 262
salbutamol (259) 259
formoterol (255) 255
medicine, general & internal (250) 250
drug therapy (249) 249
adrenergic beta-agonists - pharmacology (241) 241
forced expiratory volume - drug effects (233) 233
cross-over studies (225) 225
drug combinations (219) 219
bronchodilator agents - adverse effects (216) 216
chronic obstructive pulmonary disease (215) 215
animals (214) 214
dose-response relationship, drug (211) 211
obstructive pulmonary-disease (193) 193
time factors (193) 193
allergy (192) 192
copd (189) 189
bronchodilator agents - pharmacology (186) 186
anti-asthmatic agents - administration & dosage (176) 176
adrenergic beta-agonists - adverse effects (174) 174
inhaled corticosteroids (173) 173
albuterol (170) 170
corticosteroids (168) 168
anti-asthmatic agents - therapeutic use (167) 167
immunology (164) 164
pulmonary disease, chronic obstructive - physiopathology (162) 162
lung diseases, obstructive (157) 157
forced expiratory volume (156) 156
budesonide (154) 154
ethanolamines - therapeutic use (152) 152
tiotropium bromide (147) 147
respiratory function tests (146) 146
drug administration schedule (145) 145
ethanolamines - administration & dosage (145) 145
adrenal cortex hormones - administration & dosage (144) 144
nebulizers and vaporizers (144) 144
randomized controlled trials as topic (144) 144
quality of life (142) 142
tiotropium (127) 127
efficacy (126) 126
adrenal cortex hormones - therapeutic use (120) 120
cardiac & cardiovascular systems (119) 119
therapy (119) 119
agonist (118) 118
respiratory tract diseases (116) 116
scopolamine derivatives - therapeutic use (115) 115
exacerbations (114) 114
analysis (112) 112
powders (109) 109
aged, 80 and over (107) 107
research (107) 107
severity of illness index (106) 106
critical care medicine (103) 103
androstadienes - adverse effects (102) 102
particle size (102) 102
children (101) 101
inflammation (99) 99
dosage and administration (98) 98
care and treatment (97) 97
agonists (95) 95
safety (93) 93
double-blind (92) 92
inhalation (91) 91
anti-inflammatory agents - administration & dosage (90) 90
pulmonary and respiratory medicine (89) 89
lung-function (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2126) 2126
German (60) 60
French (28) 28
Japanese (27) 27
Polish (18) 18
Chinese (11) 11
Spanish (10) 10
Danish (9) 9
Romanian (4) 4
Russian (4) 4
Portuguese (3) 3
Dutch (2) 2
Norwegian (2) 2
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
Italian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Pharmaceutics, ISSN 0378-5173, 05/2019, Volume 562, pp. 351 - 358
[Display omitted] Chronic obstructive pulmonary disease (COPD) is one of the main health problems worldwide. It is characterised by chronic inflammation in the... 
Aerodynamic diameter | Chronic obstructive pulmonary disease (COPD) | Salmeterol Xinafoate (SX) | cAMP | Sodium alginate polymer | PULMONARY | VESICLES | CHITOSAN | RIFAMPICIN | RELEASE | CARRIERS | DELIVERY | IN-VITRO | PHARMACOLOGY & PHARMACY | Lung diseases, Obstructive | Analysis | Salmeterol | Aerodynamics | Cyclic adenylic acid | Nitrates | Polymers | Drug therapy
Journal Article
Chest, ISSN 0012-3692, 04/1999, Volume 115, Issue 4, pp. 957 - 965
Journal Article
Pharmaceutical Development and Technology, ISSN 1083-7450, 02/2018, Volume 23, Issue 2, pp. 158 - 166
The aim of this study was to develop a novel fluticasone propionate (FP) and salmeterol xinafoate (SX)-loaded dry powder inhaler (DPI) system, which was... 
Dry powder inhaler | deposition | salmeterol xinafoate | lactose | powder formulation | fluticasone propionate | DESIGN | DISPERSION | COMBINATION | CARRIER PARTICLES | IN-VITRO | SALBUTAMOL SULFATE | AEROSOL PERFORMANCE | PHARMACOLOGY & PHARMACY | PARTICLE-SIZE | MULTIDOSE INHALER
Journal Article
Journal Article
Powder Diffraction, ISSN 0885-7156, 08/2015, Volume 30, Issue 4, pp. 333 - 339
The crystal structure of salmeterol xinafoate has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density... 
salmeterol xinafoate | Rietveld refinement | Serevent Diskus | density functional theory | powder diffraction
Journal Article
Advanced Powder Technology, ISSN 0921-8831, 02/2017, Volume 28, Issue 2, pp. 534 - 542
[Display omitted] •Optimized DPI formulation of fluticasone and salmeterol was developed.•The effects of carrier, leucine and manufacturing technique were... 
Salmeterol xinafoate | Dry powder inhaler | Spray drying | Leucine | Fluticasone propionate | DRUG | DEPOSITION | DISPERSION | COMBINATION | CARRIERS | ENGINEERING, CHEMICAL | AEROSOLISATION PROPERTIES | SALBUTAMOL SULFATE | ASTHMA | RESPIRABLE POWDERS | FORMULATION COMPONENTS
Journal Article
European Respiratory Journal, ISSN 0903-1936, 1999, Volume 14, Issue 2, pp. 275 - 282
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 10/2013, Volume 14, Issue 14, pp. 1993 - 2002
Journal Article
Journal Article